RA’ANANA, Israel – Nili Capital (“Nili”) announced the acquisition of Ideale Packaging (“Ideale”), a leading provider of secondary packaging solutions to Israel’s pharmaceutical industry. Founded in 1956 and headquartered in Holon, Israel, Ideale serves as a strategic partner to all of Israel’s leading pharmaceutical manufacturers, with multi-decade customer relationships built on technical expertise, integrated design services, and a long track record of consistent quality.

“Ideale has built an exceptional reputation in Israel’s pharmaceutical industry as a trusted provider of specialized secondary packaging solutions, and we are excited to support the Company’s continued success,” said Rafi Rosenberg, a Principal with Nili Capital and Ideale Board Member.

“Ideale is a special company, with a 70-year track record, deep technical capabilities, and a team that has earned the trust of the most demanding customers in Israeli pharma,” said Jonathan Zimbalist, Partner at Nili Capital. “We are excited to partner with the Ideale team and to build on their solid foundation – expanding their capabilities and continuing to deliver the quality and reliability that customers depend on.”

Terms of the transaction were not disclosed. Ideale is Nili’s first investment out of Nili II. Kroll served as financial advisor and Goldfarb Gross Seligman served as legal advisor to Nili Capital. Bank Hapoalim provided acquisition financing.

About Ideale Packaging

Founded in 1956 and headquartered in Holon, Israel, Ideale Packaging is a leading provider of secondary packaging solutions to the pharmaceutical industry. The Company partners with Israel’s leading pharmaceutical manufacturers, offering integrated design, engineering, and production capabilities backed by a multi-decade track record of consistent quality.

About Nili Capital

Nili Capital is a private equity firm focused on small market buyouts, providing a unique solution to the hyper-competitive lower middle market. Utilizing an aggressive buy and build strategy, Nili aims to transform innovative Israeli companies into larger international companies through cross-border acquisitions in Europe and the US. Nili’s investment approach is to work with management teams to provide the necessary capital, network, and know-how to maximize growth. More information about Nili may be found at www.nilicapital.com.